F15.980
Other stimulant use, unspecified with stimulant-induced anxiety disorder
Clinical Classification Guidelines
Inclusion Terms
- Amphetamine or other stimulant-induced anxiety disorder, without use disorder
- Caffeine induced anxiety disorder, without use disorder
Medical Intelligence & Overview
ICD-10 code F15.980 refers to cases where an individual experiences anxiety triggered by the use of stimulants, such as amphetamines or caffeine, without developing a formal stimulant use disorder. This condition highlights the psychological and physical effects stimulants can have, even when they are used without addiction or dependence. Recognizing the symptoms associated with stimulant-induced anxiety is important for appropriate management and understanding the impact of stimulant substances on mental health.
Causes & Symptoms
Clinical Causes: Use of stimulant substances such as caffeine, amphetamines, or other similar drugs Physiological response to stimulant intake that surpasses typical effects, leading to anxiety Genetic predisposition to anxiety or stimulant sensitivity Environmental or psychological stressors combined with stimulant use Situations where stimulants are used to enhance alertness or performance unexpectedly trigger anxiety responses
Key Symptoms: Restlessness or feeling on edge Rapid heartbeat or palpitations Tremors or shaking Sweating excessively Difficulty sleeping or insomnia Feelings of nervousness or apprehension Dizziness or lightheadedness Muscle tension or aches Gastrointestinal discomfort such as nausea or stomach upset Shortness of breath or a sensation of choking
Diagnostic & Treatment
Diagnosis Path: Diagnosis of stimulant-induced anxiety disorder involves a detailed medical history focusing on recent stimulant use and evaluation of symptom onset relative to stimulant intake. Healthcare providers may perform physical examinations and recommend tests to rule out other medical causes of anxiety-like symptoms. Mental health assessments are used to determine the severity and impact of symptoms. The diagnosis aligns with criteria from psychiatric manuals, noting the presence of anxiety symptoms directly attributable to stimulant consumption without a separate anxiety disorder diagnosis.
Treatment Protocols: Ceasing or reducing the use of stimulant substances Engaging in relaxation techniques such as deep breathing or mindfulness exercises Psychotherapy modalities like cognitive-behavioral therapy (CBT) to develop coping strategies Medication may be prescribed in some cases to control severe anxiety symptoms, under medical supervision Lifestyle modifications, including regular exercise, adequate sleep, and avoiding caffeine or other stimulants Monitoring for potential progression to a stimulant use disorder or other related mental health issues
Clinical Advice & FAQs
Billing Guidance
Is F15.980 a billable ICD-10 code?
Yes, F15.980 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F15.980?
Clinical documentation must specify the nature of Other stimulant use, unspecified with stimulant-induced anxiety disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference